Comparison of Ranibizumab and Aflibercept for Neovascular Age-related Macular Degeneration (namd) Using a Treat-and-extend Regimen: Results of the 24-month Secondary Efficacy Outcomes From the Rival Study, a Randomized Clinical Trial
Year: 2018
Type: conference-paper
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2970751422
